The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand. On ...

A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...

INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundred… ...

A federal judge has sided with the FDA over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list ...

The FDA added Eli Lilly’s diabetes drugs Mounjaro and Trulicity to its list of medications in short supply Dec. 15. Pharmacies may receive delayed shipments for some doses of Mounjaro and ...

A long list of cancer treatment drugs are in short supply, prompting doctors to make difficult decisions about how they treat their patients. According to the FDA, 14 drugs used for chemotherapy ...

Dr. Scott Gottlieb, former FDA commissioner and Pfizer board member, warned that proposed tariffs on pharmaceutical imports could destabilize the U.S. generic drug supply. In an interview with ...